Skip to content

Sayana-Uniject Volumetric Delivery

Quantitative Determination of the Volume of Suspension Delivered Via the Uniject Delivery System Following Simulated Subcutaneous Injection by Healthcare Professionals Into a Synthetic Subcutaneous Injection Training Device

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01298479
Enrollment
25
Registered
2011-02-17
Start date
2010-05-31
Completion date
2010-06-30
Last updated
2018-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volume Delivery

Keywords

volume delivery

Brief summary

The purpose of this study is to determine the volumetric delivery of the Uniject.

Detailed description

Observe subjects deliver the drug None used

Interventions

OTHERUniject

single use container

Sponsors

Pfizer
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Nurses

Exclusion criteria

* Non-nurses

Design outcomes

Primary

MeasureTime frame
Weight of drug suspension delivered (estimated by change in mass of the Uniject(TM) delivery system).Visit 1

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026